A Study of Spoken Language in Mania
Recruiting
This research is being done to find if there are changes with voice and speech during episodes of mania.
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
06/03/2025
Locations: Mayo Clinic Minnesota, Rochester, Minnesota
Conditions: Manic Episode, Bipolar I Disorder
A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Recruiting
This is a Phase 1/2, multicenter, open-label (unless otherwise specified in a combination-specific module) study of inlexisertib in combination with anticancer therapies. Modules within the master protocol are defined according to different combinations of inlexisertib with other anticancer agents.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/03/2025
Locations: University of Southern California - Norris Comprehensive Cancer Center, Los Angeles, California +8 locations
Conditions: GIST
MED-EL Remote Care Multi-Center Feasibility Study
Recruiting
MED-EL Remote Care is a way for MED-EL cochlear implant users to check their hearing and cochlear implant device from any location, without the need for a scheduled, in-person appointment with their audiologist. This study will assess the effectiveness, efficiencies, and useability of MED-EL Remote Care.
Gender:
ALL
Ages:
All
Trial Updated:
06/03/2025
Locations: University of Iowa Hospitals and Clinics, Iowa City, Iowa +4 locations
Conditions: Hearing Loss, Sensorineural, Cochlear Implant, Cochlear Implant Recipients, Hearing Disorders, Cochlear Implants
A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology
Recruiting
To learn about the effects of paclitaxel and gastrectomy (surgery to remove all or part of the stomach) on improving outcomes in patients with gastric cancer.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/03/2025
Locations: M D Anderson Cancer Center, Houston, Texas
Conditions: Gastric Adenocarcinoma, Carcinomatosis
Deconstructing Post Stroke Hemiparesis
Recruiting
TRACTs (DeconsTructing Post StRoke HemipAresis for PreCision NeurorehabiliTation) is a single timepoint study that aims to deconstruct post-stroke deficits of the upper extremity into distinct components and relate these components to brain anatomy and physiology.
Gender:
ALL
Ages:
Between 18 years and 90 years
Trial Updated:
06/03/2025
Locations: Providence VA Medical Center, Providence, Rhode Island
Conditions: Stroke
Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Paranteral Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Randomized Controlled Study
Recruiting
The goal of this research study is to learn if feeding someone after a stem cell transplant is safe and practical.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/03/2025
Locations: M D Anderson Cancer Center, Houston, Texas
Conditions: Stem Cell
Exercise to Boost Response to Checkpoint Blockade Immunotherapy
Recruiting
The purpose of this pilot study will be to provide i) information on feasibility implementing an exercise intervention trial among patients with cutaneous cancers, including melanoma, squamous cell carcinoma (cuSCC), and Merkel cell carcinoma, scheduled to receive checkpoint blockade immunotherapy, and ii) preliminary data on the impact of a day-of-therapy exercise intervention.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/03/2025
Locations: AdventHealth Translational Research Institute, Orlando, Florida
Conditions: Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma
A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
Recruiting
To learn about the safety of a drug called axicabtagene ciloleucel given in combination with radiation therapy to patients with relapsed/refractory FL.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/03/2025
Locations: MD Anderson Cancer Center, Houston, Texas
Conditions: Follicular Lymphoma
A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors
Recruiting
The primary purpose of this study is to determine the maximum tolerated dose of GSK4524101 monotherapy (MTD) and GSK4524101 in combination with niraparib (MTDc). The study consists of two parts - Part 1 (Dose Escalation) and Part 2 (Dose Expansion).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/03/2025
Locations: GSK Investigational Site, San Francisco, California +8 locations
Conditions: Neoplasms
Pulse-Width Modulation
Recruiting
The overarching aim of this project is to modulate the pulse-width during stimulation of pedicle screws and record the response thresholds associated with each PWM setting. During this initial phase of the investigation, no further data will be collected.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/03/2025
Locations: Dartmouth-Health, Lebanon, New Hampshire
Conditions: Spinal Fusion, Spinal Stenosis
Autologous Bone Marrow Aspirate Treatment for Early-Stage Osteonecrosis
Recruiting
Osteonecrosis of the femoral head (ONFH) is a debilitating musculoskeletal disease that is characterized by localized death of bone cells and associated cellular elements within the subchondral bone. If it progresses, it results in the collapse of the femoral head (ball part of the hip) giving rise to secondary arthritis. This condition is associated with marked pain and loss of function, often necessitating a joint replacement. Due to the relatively young age of onset of ONFH (often in 20s and... Read More
Gender:
ALL
Ages:
Between 18 years and 90 years
Trial Updated:
06/03/2025
Locations: University of Southern California, Los Angeles, California +11 locations
Conditions: Osteonecrosis of the Femoral Head, Avascular Necrosis of the Femoral Head
A Digital Art Activity to Enhance Self-Disclosure and the Detection of Psycho-social Distress in Adult Cancer Patients
Recruiting
To look at how a digital art activity may help cancer patients improve their ability to express their distress, symptoms, and lived experience.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/03/2025
Locations: MD Anderson Cancer Center, Houston, Texas
Conditions: Cancer